For this month’s edition of 5 Interesting Startup Deals, all the funded companies that caught our eye were hardware-centric, from a medical device for at-home acne treatment, to an artificial retina ...

Here's how Hims & Hers co-founder, Joe Spector, built in one of the hardest sectors and how to break into a complex market.

Watch baby burst into giggles as boxer dog gets the zoomies Trump Is Very Confused About Nuclear Weapons Woman Buys Home, Then Realizes Crucial Error: 'There's Nothing I Can Do' Prince Andrew stripped ...

At last check, HIMS was up 0.8% to trade at $47.82. It looks like the stock could continue higher, too, as those recent losses placed the shares near a long-term trendline that has historically ...

Queensland Alliance for Environmental Health Sciences (QAEHS), 20 Cornwall Street, Woolloongabba, Brisbane, QLD 4102, Australia ARC Training Centre for Hyphenated Analytical Separation Technologies ...

Hims & Hers (NYSE:HIMS) traded lower in the morning hours on Tuesday after KeyBanc Capital Markets launched its coverage with a Sector Weight recommendation, citing concerns over the company's margins ...

Fintel reports that on October 21, 2025, Keybanc initiated coverage of Hims & Hers Health (NYSE:HIMS) with a Sector Weight recommendation. Analyst Price Forecast Suggests 3.04% Downside As of ...

Hims & Hers Health launched menopause and low testosterone products in the last month, expanding its addressable market and supporting its $6.5 billion 2030 revenue target. Recent product launches, ...